000756SZSE

2026 First Quarter Report

Shandong Xinhua Pharmaceutical Company Limited··9 pages

✨ AI Summary

This report details the company's 2026 first quarter financial performance. Operating income slightly decreased by 0.28% to CNY 2,423,049,619.10. Total profit saw a significant drop of 25.51% to CNY 83,903,044.36, and net profit attributable to shareholders was a loss of CNY 116,552,703.09, a 1,483.38% decrease. The company plans to adjust its financial policies.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Important Content Reminder:

  1. The board of directors and senior management confirm that the content of the report is true, accurate, complete, and free from false records, misleading statements, or major omissions.
  2. The person in charge of the company, the principal accounting officer, and the accounting institution confirm that the financial information in the report is true, accurate, and complete.
  3. The first quarter report has been audited.

I. Main Business Data

(1) Main Financial Data and Business Indicators

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing